Systemic treatment with GM1 ganglioside improves survival and function of cryopreserved embryonic midbrain grafted to the 6-hydroxydopamine-lesioned rat striatum. [electronic resource]
Producer: 20000816Description: 121-9 p. digitalISSN:- 0014-4886
- Animals
- Brain Tissue Transplantation
- Cell Count -- drug effects
- Cell Survival -- drug effects
- Corpus Striatum -- cytology
- Cryopreservation -- methods
- Disease Models, Animal
- Female
- Fetal Tissue Transplantation
- G(M1) Ganglioside -- pharmacology
- Graft Survival -- drug effects
- Mesencephalon -- cytology
- Motor Activity -- drug effects
- Neurons -- cytology
- Neuroprotective Agents -- pharmacology
- Oxidopamine
- Parkinson Disease, Secondary -- chemically induced
- Pregnatrienes -- pharmacology
- Rats
- Rats, Sprague-Dawley
- Recovery of Function -- drug effects
- Tyrosine 3-Monooxygenase -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.